Inflation is getting worse, Americans are feeling the impact Ivar AI

Abcnews.com

SpaceX's IPO is set to be the biggest ever and could make Elon Musk a trillionaire

Business Insider

US stocks tumble and bond yields rise toward key levels as the Iran war heats up again

Expansion.com

Alphabet venderá 80.000 millones de dólares en acciones para invertir en desarrollo de IA

Fortune

Mark Cuban put $500K into a stranger’s rocket company over email. It’s now a SpaceX competitor worth $4 billion

Crypto Briefing

SpaceX eyes $1.75T valuation in IPO next week, potentially making Musk the world’s first trillionaire

Forbes

Tech CEO With $35 Million California Mansion Charged With Secretly Aiding Iran’s Nuclear Program

Biziday.ro

Nvidia a lansat primul cip de inteligență artificială pentru computere personale. Acesta va permite rularea de agenți AI pe dispozitiv, care vor putea exercita sarcini autonom și vor face navigarea mai ușoară.

El Financiero

Musk, cerca de ser trillonario: SpaceX busca recaudar 75 mil mdd en la mayor salida a bolsa de la historia

Nacion.com

Alphabet, matriz de Google, ampliará capital en $80.000 millones para impulsar la IA

Www.df.cl

SpaceX ya fijó el monto de la apertura a bolsa: busca recaudar un récord de US$ 75 mil millones

Diariobitcoin.com

Ethena (ENA) 2026-06-03: repunte del 30% alerta a los mercados

Yahoo Entertainment

伊朗傳終止美伊對話油價跳漲逾4% 荷姆茲海峽封鎖風險增

Olhardigital.com.br

Dona do Google anuncia venda de ações para investir em IA

TechCrunch

Defense tech darling Mach Industries hits $1.8B valuation, a 4x jump in a year | TechCrunch

Foreign Policy

Russia Pounds Ukraine With Missile, Drone Strikes

gcaptain.com

Taiwan Beefs up Anti-Ship Missile Arsenal to Counter Threat of Chinese Invasion

CNA

Instant View: Anthropic IPO filing ratifies Wall Street's AI obsession

CBS News

U.S.-Iran tensions escalate with new strikes despite ceasefire

STERN.de

Börsengang: SpaceX will 75 Milliarden Dollar einnehmen - Ausgabepreis von 135 Dollar

PRNewswire

Demand for Compounding Pharmacies in USA to Reach USD 12.79 Billion by 2036 Amid Growing Need for Personalized Therapies and Specialized Medication Solutions